Weight-Loss Drug Zepbound Faces Supply Issues Following weight-loss indication, patients struggle to obtain tirzepatide Apr 02, 2024
Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes? News and commentary from the endocrinology world Apr 02, 2024
GLP-1 Users May Have Increased Endoscopy-Related Aspiration Pneumonia Risk Overall incidence is still low, however Apr 01, 2024
When Medicalization Goes Too Far The boundaries between health and disease often get a little blurry Mar 31, 2024
Here's What OTC Continuous Glucose Monitors Can Do for Our Patients FDA's approval may be a step toward greater access Mar 30, 2024
Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? News and commentary from the endocrinology world Mar 26, 2024
Out-of-Pocket Insulin Caps Boost Savings -- But Not Insulin Use Proposed national $35 insulin cap would help some patients, researchers say Mar 25, 2024
Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures? News and commentary from the endocrinology world Mar 19, 2024
Is SGLT2 Inhibitor-Associated Ketoacidosis Treated With Enough Insulin? Study suggests these patients receive significantly lower doses vs those with T1D ketoacidosis Mar 18, 2024
Slowing of Peripheral Artery Disease: Another Liraglutide Benefit? GLP-1 receptor agonist significantly slowed progression over 6 months Mar 13, 2024
Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes News and commentary from the endocrinology world Mar 12, 2024
Deaths Due to Alcohol Use; Steps for the Sedentary Also in TTHealthWatch: microplastics in arteries, and worldwide obesity and diabetes risk Mar 09, 2024 podcast
Cardiometabolic Disorders Tend to Accompany a 'Lazy Eye' Persistent amblyopia associated with myocardial infarction and death Mar 08, 2024
One-Week GLP-1 Agonist Hold Not Enough Before Anesthesia? Even following this rule, increased residual gastric content still prevalent Mar 07, 2024
FDA Clears First OTC Continuous Glucose Monitor Dexcom's Stelo system available without a prescription by the summer Mar 06, 2024
Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D News and commentary from the endocrinology world Mar 05, 2024
FDA Says Eating Yogurt May Reduce Diabetes Risk Products will be allowed to carry claims as long as they don't mislead consumers Mar 04, 2024
Bariatric Surgery a Long-Term Winner for Type 2 Diabetes Clinical trials show advantages over lifestyle, medication out to 12 years Feb 27, 2024
FDA: Don't Use Smartwatches, Smart Rings for Blood Glucose Measurements Noninvasive devices that don't pierce the skin can give inaccurate measurements Feb 22, 2024
T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicals News and commentary from the endocrinology world Feb 20, 2024
States Target Health Insurers' Red Tape Around Prior Authorization Pending bills in multiple states include policies backed by the AMA Feb 19, 2024
SGLT2 Inhibitors Tied to Better NAFLD Outcomes vs Other Antidiabetic Agents Class of drug associated with highest odds of NAFLD regression for patients with type 2 diabetes Feb 14, 2024
Denosumab Protective Against Diabetes? Study found lower diabetes incidence with osteoporosis drug for patients who stayed on treatment Feb 13, 2024
Rapid Weight Loss a Diabetic Retinopathy Risk? While research is conflicting, GLP-1 therapies might cause transient worsening of retinal disease Feb 12, 2024
Can a Common Diabetes Drug Turn Patients' Urine Into Alcohol? Case study highlights importance of proper urine sample storage Feb 07, 2024
More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk News and commentary from the endocrinology world Feb 06, 2024
Durable Weight Loss Follows Just a Few Injections of Novel Drug Most of the body weight reduction persisted 150 days after the last dose in an early-phase trial Feb 05, 2024
Health Effects of Diabetes Remission; High-Deductible Plans for Cancer Patients Also in TTHealthWatch: USPSTF weighs in on screening for language disorders or delays in kids Feb 03, 2024 podcast
Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supply News and commentary from the endocrinology world Jan 30, 2024
Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Care Study looked at how three recommendations changed primary care decisions Jan 29, 2024
One Class of Antidiabetic Linked With Lower Kidney Stone Risk Study compared SGLT2 inhibitors with GLP-1 agonists and DPP-4 inhibitors Jan 29, 2024
Can the Eye Reveal Cardiac and Lung Disease -- Plus Much More? Researchers link thinner retinal layers to higher risk of multiple diseases Jan 26, 2024
Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism Daily treatment substantially reduced hypoglycemia over 13 weeks Jan 24, 2024
T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans? News and commentary from the endocrinology world Jan 23, 2024
Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain News and commentary from the endocrinology world Jan 16, 2024
FDA Clears Wegovy, Other GLP-1 Drugs of Suicidality Risk for Now Preliminary evaluation reassures, while the agency's review continues Jan 11, 2024
T1D Trial Paused After Deaths; Mounjaro Not Just Cosmetic; Late-Stage Hot Flash Win News and commentary from the endocrinology world Jan 09, 2024
No Increased Risk of Suicidal Ideation With GLP-1 Drugs Semaglutide shows lower risk of suicidal ideation than other obesity, diabetes drugs Jan 08, 2024
Maternal Type 1 Diabetes an Outsized Red Flag for Child Heart Defect Risk But don't ignore maternal overweight, obesity, and gestational diabetes, study says Jan 05, 2024
Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists Researchers looked at 7-year patient data Jan 04, 2024